US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist
  • 144.470
  • +0.890+0.62%
Close Dec 20 16:00 ET
  • 144.470
  • 0.0000.00%
Post 20:01 ET
347.83BMarket Cap23.49P/E (TTM)

Johnson & Johnson Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jun 30, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-13.67%20.3B
-10.63%25.48B
6.52%26.22B
2.90%22.93B
2.90%22.93B
-31.01%23.51B
-12.48%28.51B
-19.00%24.61B
-29.51%22.28B
-29.51%22.28B
-Cash and cash equivalents
1.28%19.98B
17.44%24.88B
32.88%25.47B
69.59%21.86B
69.59%21.86B
73.74%19.73B
92.87%21.18B
83.22%19.17B
-11.03%12.89B
-11.03%12.89B
-Short-term investments
-91.62%317M
-91.85%597M
-86.31%745M
-88.63%1.07B
-88.63%1.07B
-83.35%3.78B
-66.08%7.32B
-72.68%5.44B
-45.14%9.39B
-45.14%9.39B
Receivables
9.30%16.17B
-5.86%15.79B
-8.59%14.95B
14.61%19.39B
14.61%19.39B
-6.87%14.8B
3.95%16.78B
4.85%16.35B
-10.90%16.92B
-10.90%16.92B
-Accounts receivable
9.30%16.17B
-5.86%15.79B
-8.59%14.95B
5.94%14.87B
5.94%14.87B
-6.87%14.8B
3.95%16.78B
4.85%16.35B
-8.14%14.04B
-8.14%14.04B
-Other receivables
----
----
----
56.95%4.51B
56.95%4.51B
----
----
----
-22.29%2.88B
-22.29%2.88B
Inventory
12.55%12.6B
-5.58%12.17B
-11.13%11.38B
8.89%11.18B
8.89%11.18B
-4.09%11.2B
12.69%12.89B
16.55%12.81B
-1.15%10.27B
-1.15%10.27B
Restricted cash
----
----
----
----
----
----
----
--7.7B
----
----
Other current assets
-0.50%4.18B
82.69%4.38B
52.52%4.46B
----
----
16.82%4.2B
-35.27%2.4B
-15.38%2.92B
----
----
Total current assets
-0.85%53.25B
-4.54%57.82B
-11.47%57B
-3.25%53.5B
-3.25%53.5B
-17.68%53.7B
-5.14%60.57B
6.56%64.39B
-9.32%55.29B
-9.32%55.29B
Non current assets
Net PPE
8.81%20.48B
-4.02%19.75B
-2.69%19.63B
10.66%19.9B
10.66%19.9B
3.69%18.82B
12.11%20.58B
7.88%20.17B
-5.17%17.98B
-5.17%17.98B
-Gross PPE
8.00%49.27B
-6.21%48.04B
-5.52%47.59B
9.74%47.78B
9.74%47.78B
-2.26%45.63B
8.64%51.22B
5.59%50.37B
-8.69%43.53B
-8.69%43.53B
-Accumulated depreciation
-7.42%-28.8B
7.69%-28.29B
7.42%-27.95B
-9.10%-27.88B
-9.10%-27.88B
6.04%-26.81B
-6.43%-30.64B
-4.11%-30.19B
11.02%-25.55B
11.02%-25.55B
Goodwill and other intangible assets
18.47%84.29B
-8.41%83.98B
-23.78%70.9B
-5.10%70.73B
-5.10%70.73B
-3.49%71.15B
19.74%91.69B
17.22%93.02B
-8.70%74.54B
-8.70%74.54B
-Goodwill
24.01%44.8B
-2.62%44.25B
-19.66%36.62B
1.42%36.56B
1.42%36.56B
8.21%36.12B
33.00%45.44B
30.46%45.58B
2.27%36.05B
2.27%36.05B
-Other intangible assets
12.76%39.49B
-14.10%39.73B
-27.74%34.29B
-11.21%34.18B
-11.21%34.18B
-13.18%35.02B
9.05%46.25B
6.82%47.45B
-17.04%38.49B
-17.04%38.49B
Non current deferred assets
0.97%9.35B
2.56%9B
16.88%10.31B
3.71%9.28B
3.71%9.28B
-1.42%9.26B
-7.73%8.78B
-11.26%8.82B
-12.48%8.95B
-12.48%8.95B
Other non current assets
-16.84%10.92B
4.62%10.54B
47.64%14.13B
-53.78%14.15B
-53.78%14.15B
52.27%13.13B
6.82%10.08B
-3.74%9.57B
199.72%30.62B
199.72%30.62B
Total non current assets
11.29%125.04B
-5.99%123.27B
-12.63%114.96B
-13.64%114.06B
-13.64%114.06B
2.25%112.36B
15.14%131.12B
11.57%131.58B
9.13%132.08B
9.13%132.08B
Total assets
7.36%178.29B
-5.53%181.09B
-12.25%171.97B
-10.58%167.56B
-10.58%167.56B
-5.18%166.06B
7.86%191.69B
9.88%195.97B
2.94%187.38B
2.94%187.38B
Liabilities
Current liabilities
Payables
22.52%13.79B
0.21%13.16B
-18.93%11.49B
4.26%12.63B
4.26%12.63B
-7.29%11.25B
11.79%13.13B
28.66%14.18B
-0.48%12.11B
-0.48%12.11B
-accounts payable
7.17%8.95B
-15.27%8.85B
-17.51%8.17B
-2.60%9.63B
-2.60%9.63B
-17.71%8.36B
6.94%10.44B
6.45%9.91B
-10.55%9.89B
-10.55%9.89B
-Total tax payable
66.75%4.83B
60.36%4.31B
-22.22%3.32B
34.82%2.99B
34.82%2.99B
45.97%2.9B
35.71%2.69B
149.77%4.27B
99.64%2.22B
99.64%2.22B
Current accrued expenses
15.36%29.89B
6.85%28.08B
1.99%26.51B
7.88%26.21B
7.88%26.21B
-0.25%25.91B
0.86%26.28B
0.04%25.99B
-5.48%24.3B
-5.48%24.3B
Current debt and capital lease obligation
15.30%4.46B
-15.78%9.86B
-52.44%8.55B
-72.95%3.45B
-72.95%3.45B
-12.52%3.87B
171.80%11.7B
318.41%17.98B
238.71%12.76B
238.71%12.76B
-Current debt
15.30%4.46B
-15.78%9.86B
-52.44%8.55B
-72.95%3.45B
-72.95%3.45B
-12.52%3.87B
171.80%11.7B
318.41%17.98B
238.71%12.76B
238.71%12.76B
Other current liabilities
----
----
----
----
----
----
----
----
--3.59B
--3.59B
Current liabilities
16.65%51.76B
-0.44%53.93B
-19.29%48.73B
-17.06%46.28B
-17.06%46.28B
-2.58%44.37B
20.86%54.17B
39.14%60.37B
23.38%55.8B
23.38%55.8B
Non current liabilities
Long term debt and capital lease obligation
20.11%31.29B
-6.68%31.64B
-28.19%25.08B
-3.74%25.88B
-3.74%25.88B
-5.62%26.05B
19.83%33.9B
21.06%34.93B
-10.34%26.89B
-10.34%26.89B
-Long term debt
20.11%31.29B
-6.68%31.64B
-28.19%25.08B
-3.74%25.88B
-3.74%25.88B
-5.62%26.05B
19.83%33.9B
21.06%34.93B
-10.34%26.89B
-10.34%26.89B
Non current deferred liabilities
12.54%2.95B
-27.35%2.64B
-28.19%3.17B
-19.99%3.19B
-19.99%3.19B
-46.97%2.62B
-27.68%3.63B
-31.24%4.42B
-46.69%3.99B
-46.69%3.99B
Employee benefits
20.49%6.85B
7.09%6.92B
5.31%7.02B
9.28%7.15B
9.28%7.15B
-31.92%5.69B
-24.46%6.46B
-23.73%6.67B
-26.48%6.54B
-26.48%6.54B
Other non current liabilities
10.04%14.92B
-3.40%14.09B
4.48%15.07B
32.05%13.4B
32.05%13.4B
36.74%13.56B
38.56%14.58B
37.38%14.42B
-5.05%10.15B
-5.05%10.15B
Total non current liabilities
11.71%56.37B
-8.98%55.62B
-17.78%53.22B
-4.14%52.5B
-4.14%52.5B
-8.22%50.46B
8.07%61.11B
7.42%64.73B
-12.74%54.77B
-12.74%54.77B
Total liabilities
14.02%108.13B
-4.97%109.55B
-18.51%101.95B
-10.66%98.78B
-10.66%98.78B
-5.66%94.83B
13.72%115.28B
20.70%125.1B
2.39%110.57B
2.39%110.57B
Shareholders'equity
Share capital
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
-common stock
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
0.00%3.12B
-Preferred stock
----
----
----
--0
--0
----
----
----
--0
--0
Paid-in capital
1.73%155.18B
20.08%155.36B
23.14%153.38B
19.87%153.84B
19.87%153.84B
19.25%152.54B
2.51%129.38B
0.14%124.56B
4.29%128.35B
4.29%128.35B
Less: Treasury stock
-0.04%75.62B
71.18%75.69B
71.36%75.71B
81.47%75.66B
81.47%75.66B
83.85%75.65B
12.98%44.22B
13.19%44.18B
6.64%41.69B
6.64%41.69B
Gains losses not affecting retained earnings
-42.62%-12.52B
14.33%-11.25B
14.72%-10.77B
3.39%-12.53B
3.39%-12.53B
42.58%-8.78B
5.11%-13.14B
8.22%-12.63B
0.70%-12.97B
0.70%-12.97B
Total stockholders'equity
-1.50%70.16B
-4.81%71.54B
-1.20%70.02B
-10.46%68.77B
-10.46%68.77B
-4.52%71.23B
-1.58%75.15B
-5.14%70.87B
3.76%76.8B
3.76%76.8B
Noncontrolling interests
----
----
----
----
----
----
--1.26B
----
----
----
Total equity
-1.50%70.16B
-6.37%71.54B
-1.20%70.02B
-10.46%68.77B
-10.46%68.77B
-4.52%71.23B
0.07%76.41B
-5.14%70.87B
3.76%76.8B
3.76%76.8B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jun 30, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -13.67%20.3B-10.63%25.48B6.52%26.22B2.90%22.93B2.90%22.93B-31.01%23.51B-12.48%28.51B-19.00%24.61B-29.51%22.28B-29.51%22.28B
-Cash and cash equivalents 1.28%19.98B17.44%24.88B32.88%25.47B69.59%21.86B69.59%21.86B73.74%19.73B92.87%21.18B83.22%19.17B-11.03%12.89B-11.03%12.89B
-Short-term investments -91.62%317M-91.85%597M-86.31%745M-88.63%1.07B-88.63%1.07B-83.35%3.78B-66.08%7.32B-72.68%5.44B-45.14%9.39B-45.14%9.39B
Receivables 9.30%16.17B-5.86%15.79B-8.59%14.95B14.61%19.39B14.61%19.39B-6.87%14.8B3.95%16.78B4.85%16.35B-10.90%16.92B-10.90%16.92B
-Accounts receivable 9.30%16.17B-5.86%15.79B-8.59%14.95B5.94%14.87B5.94%14.87B-6.87%14.8B3.95%16.78B4.85%16.35B-8.14%14.04B-8.14%14.04B
-Other receivables ------------56.95%4.51B56.95%4.51B-------------22.29%2.88B-22.29%2.88B
Inventory 12.55%12.6B-5.58%12.17B-11.13%11.38B8.89%11.18B8.89%11.18B-4.09%11.2B12.69%12.89B16.55%12.81B-1.15%10.27B-1.15%10.27B
Restricted cash ------------------------------7.7B--------
Other current assets -0.50%4.18B82.69%4.38B52.52%4.46B--------16.82%4.2B-35.27%2.4B-15.38%2.92B--------
Total current assets -0.85%53.25B-4.54%57.82B-11.47%57B-3.25%53.5B-3.25%53.5B-17.68%53.7B-5.14%60.57B6.56%64.39B-9.32%55.29B-9.32%55.29B
Non current assets
Net PPE 8.81%20.48B-4.02%19.75B-2.69%19.63B10.66%19.9B10.66%19.9B3.69%18.82B12.11%20.58B7.88%20.17B-5.17%17.98B-5.17%17.98B
-Gross PPE 8.00%49.27B-6.21%48.04B-5.52%47.59B9.74%47.78B9.74%47.78B-2.26%45.63B8.64%51.22B5.59%50.37B-8.69%43.53B-8.69%43.53B
-Accumulated depreciation -7.42%-28.8B7.69%-28.29B7.42%-27.95B-9.10%-27.88B-9.10%-27.88B6.04%-26.81B-6.43%-30.64B-4.11%-30.19B11.02%-25.55B11.02%-25.55B
Goodwill and other intangible assets 18.47%84.29B-8.41%83.98B-23.78%70.9B-5.10%70.73B-5.10%70.73B-3.49%71.15B19.74%91.69B17.22%93.02B-8.70%74.54B-8.70%74.54B
-Goodwill 24.01%44.8B-2.62%44.25B-19.66%36.62B1.42%36.56B1.42%36.56B8.21%36.12B33.00%45.44B30.46%45.58B2.27%36.05B2.27%36.05B
-Other intangible assets 12.76%39.49B-14.10%39.73B-27.74%34.29B-11.21%34.18B-11.21%34.18B-13.18%35.02B9.05%46.25B6.82%47.45B-17.04%38.49B-17.04%38.49B
Non current deferred assets 0.97%9.35B2.56%9B16.88%10.31B3.71%9.28B3.71%9.28B-1.42%9.26B-7.73%8.78B-11.26%8.82B-12.48%8.95B-12.48%8.95B
Other non current assets -16.84%10.92B4.62%10.54B47.64%14.13B-53.78%14.15B-53.78%14.15B52.27%13.13B6.82%10.08B-3.74%9.57B199.72%30.62B199.72%30.62B
Total non current assets 11.29%125.04B-5.99%123.27B-12.63%114.96B-13.64%114.06B-13.64%114.06B2.25%112.36B15.14%131.12B11.57%131.58B9.13%132.08B9.13%132.08B
Total assets 7.36%178.29B-5.53%181.09B-12.25%171.97B-10.58%167.56B-10.58%167.56B-5.18%166.06B7.86%191.69B9.88%195.97B2.94%187.38B2.94%187.38B
Liabilities
Current liabilities
Payables 22.52%13.79B0.21%13.16B-18.93%11.49B4.26%12.63B4.26%12.63B-7.29%11.25B11.79%13.13B28.66%14.18B-0.48%12.11B-0.48%12.11B
-accounts payable 7.17%8.95B-15.27%8.85B-17.51%8.17B-2.60%9.63B-2.60%9.63B-17.71%8.36B6.94%10.44B6.45%9.91B-10.55%9.89B-10.55%9.89B
-Total tax payable 66.75%4.83B60.36%4.31B-22.22%3.32B34.82%2.99B34.82%2.99B45.97%2.9B35.71%2.69B149.77%4.27B99.64%2.22B99.64%2.22B
Current accrued expenses 15.36%29.89B6.85%28.08B1.99%26.51B7.88%26.21B7.88%26.21B-0.25%25.91B0.86%26.28B0.04%25.99B-5.48%24.3B-5.48%24.3B
Current debt and capital lease obligation 15.30%4.46B-15.78%9.86B-52.44%8.55B-72.95%3.45B-72.95%3.45B-12.52%3.87B171.80%11.7B318.41%17.98B238.71%12.76B238.71%12.76B
-Current debt 15.30%4.46B-15.78%9.86B-52.44%8.55B-72.95%3.45B-72.95%3.45B-12.52%3.87B171.80%11.7B318.41%17.98B238.71%12.76B238.71%12.76B
Other current liabilities ----------------------------------3.59B--3.59B
Current liabilities 16.65%51.76B-0.44%53.93B-19.29%48.73B-17.06%46.28B-17.06%46.28B-2.58%44.37B20.86%54.17B39.14%60.37B23.38%55.8B23.38%55.8B
Non current liabilities
Long term debt and capital lease obligation 20.11%31.29B-6.68%31.64B-28.19%25.08B-3.74%25.88B-3.74%25.88B-5.62%26.05B19.83%33.9B21.06%34.93B-10.34%26.89B-10.34%26.89B
-Long term debt 20.11%31.29B-6.68%31.64B-28.19%25.08B-3.74%25.88B-3.74%25.88B-5.62%26.05B19.83%33.9B21.06%34.93B-10.34%26.89B-10.34%26.89B
Non current deferred liabilities 12.54%2.95B-27.35%2.64B-28.19%3.17B-19.99%3.19B-19.99%3.19B-46.97%2.62B-27.68%3.63B-31.24%4.42B-46.69%3.99B-46.69%3.99B
Employee benefits 20.49%6.85B7.09%6.92B5.31%7.02B9.28%7.15B9.28%7.15B-31.92%5.69B-24.46%6.46B-23.73%6.67B-26.48%6.54B-26.48%6.54B
Other non current liabilities 10.04%14.92B-3.40%14.09B4.48%15.07B32.05%13.4B32.05%13.4B36.74%13.56B38.56%14.58B37.38%14.42B-5.05%10.15B-5.05%10.15B
Total non current liabilities 11.71%56.37B-8.98%55.62B-17.78%53.22B-4.14%52.5B-4.14%52.5B-8.22%50.46B8.07%61.11B7.42%64.73B-12.74%54.77B-12.74%54.77B
Total liabilities 14.02%108.13B-4.97%109.55B-18.51%101.95B-10.66%98.78B-10.66%98.78B-5.66%94.83B13.72%115.28B20.70%125.1B2.39%110.57B2.39%110.57B
Shareholders'equity
Share capital 0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B
-common stock 0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B0.00%3.12B
-Preferred stock --------------0--0--------------0--0
Paid-in capital 1.73%155.18B20.08%155.36B23.14%153.38B19.87%153.84B19.87%153.84B19.25%152.54B2.51%129.38B0.14%124.56B4.29%128.35B4.29%128.35B
Less: Treasury stock -0.04%75.62B71.18%75.69B71.36%75.71B81.47%75.66B81.47%75.66B83.85%75.65B12.98%44.22B13.19%44.18B6.64%41.69B6.64%41.69B
Gains losses not affecting retained earnings -42.62%-12.52B14.33%-11.25B14.72%-10.77B3.39%-12.53B3.39%-12.53B42.58%-8.78B5.11%-13.14B8.22%-12.63B0.70%-12.97B0.70%-12.97B
Total stockholders'equity -1.50%70.16B-4.81%71.54B-1.20%70.02B-10.46%68.77B-10.46%68.77B-4.52%71.23B-1.58%75.15B-5.14%70.87B3.76%76.8B3.76%76.8B
Noncontrolling interests --------------------------1.26B------------
Total equity -1.50%70.16B-6.37%71.54B-1.20%70.02B-10.46%68.77B-10.46%68.77B-4.52%71.23B0.07%76.41B-5.14%70.87B3.76%76.8B3.76%76.8B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List

Investment Theme CAR-T Therapy
CAR-T Therapy
Intraday+0.97%
Infectious Disease
Infectious Disease
Intraday+0.78%